Loading clinical trials...
Loading clinical trials...
Stargardt disease 1 (STGD1) is the most prevalent form of juvenile macular degeneration. It is caused by a rare, inherited autosomal recessive trait, leading to severe and irreversible blindness by th...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
RBP4 Pty Ltd
Collaborators
NCT07161544 · Stargardt Disease
NCT07439887 · Stargardt Disease
NCT04545736 · ABCA4 Retinopathy, Stargardt Disease, and more
NCT06319872 · Alcohol Use Disorder, Retinal Dystrophies, and more
NCT06942572 · Stargardt Disease, Stargardt Macular Degeneration, and more
Sydney Children's Hospitals Network
Westmead, New South Wales
Lions Eye Institute
Perth, Western Australia
National Taiwan University Hospital
Taipei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions